{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:49:51Z","timestamp":1789019391548,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T00:00:00Z","timestamp":1554336000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norwegian Research Council","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12879-019-3918-2","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T13:03:59Z","timestamp":1554383039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["Integrated care of severe infectious diseases to people with substance use disorders; a systematic review"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8701-7638","authenticated-orcid":false,"given":"J\u00f8rn Henrik","family":"Vold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christer","family":"Aas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Alexander","family":"Leiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Vickerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Chalabianloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else-Marie","family":"L\u00f8berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell Arne","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Thore","family":"Fadnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,4]]},"reference":[{"key":"3918_CR1","volume-title":"UNAIDS report on the global AIDS epidemic, 2012","author":"UNAIDS","year":"2012","unstructured":"UNAIDS: UNAIDS report on the global AIDS epidemic, 2012. 2012."},{"issue":"3","key":"3918_CR2","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.drugpo.2014.01.009","volume":"25","author":"N Walsh","year":"2014","unstructured":"Walsh N, Verster A, Rodolph M, Akl EA. WHO guidance on the prevention of viral hepatitis B and C among people WHO inject drugs. Int J Drug Policy. 2014;25(3):363\u201371.","journal-title":"Int J Drug Policy"},{"key":"3918_CR3","unstructured":"Policy guidelines for collaborative TB and HIV services for injecting and other drug users - an integrated approach. In.: World Health Organization, United Nations Office on Drugs and Crime, and UNAIDS; 2008."},{"key":"3918_CR4","unstructured":"Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations - 2016 update. In. \n                    https:\/\/www.who.int\/hiv\/pub\/guidelines\/keypopulations-2016\/en\/\n                    \n                  : World Health Organization; 2014."},{"key":"3918_CR5","unstructured":"Global Hepatitis Report, 2017. In. \n                    https:\/\/www.who.int\/hepatitis\/publications\/global-hepatitis-report2017\/en\/\n                    \n                  : World Health Organization; 2017: 83."},{"key":"3918_CR6","unstructured":"Global health sector strategy on HIV, 2016-2021. In.. \n                    http:\/\/www.who.int\/hiv\/strategy2016-2021\/ghss-hiv\/en\/\n                    \n                  ; World Health Organization; 2016."},{"key":"3918_CR7","unstructured":"The End TB Strategy - global strategy and targets for tuberculosis prevention, care and control after 2015. In. . \n                    http:\/\/www.who.int\/tb\/strategy\/End_TB_Strategy.pdf?ua=1\n                    \n                   World Health Organization; 2014."},{"key":"3918_CR8","unstructured":"Good Health And Well-being: Why It Matters. In. \n                    https:\/\/www.un.org\/sustainabledevelopment\/wp-content\/uploads\/2017\/03\/ENGLISH_Why_it_Matters_Goal_3_Health.pdf\n                    \n                  : United Nations Sustainable Development Goals; 2018: Goal 3."},{"issue":"6","key":"3918_CR9","doi-asserted-by":"publisher","first-page":"F45","DOI":"10.1097\/00002030-199904160-00002","volume":"13","author":"MT Schechter","year":"1999","unstructured":"Schechter MT, Strathdee SA, Cornelisse PG, Currie S, Patrick DM, Rekart ML, O'Shaughnessy MV. Do needle exchange programmes increase the spread of HIV among injection drug users?: an investigation of the Vancouver outbreak. AIDS (London, England). 1999;13(6):F45\u201351.","journal-title":"AIDS (London, England)"},{"key":"3918_CR10","unstructured":"Primary Health Care - Now More Than Ever. In.: World Health Organization; 2008."},{"issue":"1","key":"3918_CR11","doi-asserted-by":"publisher","DOI":"10.7448\/IAS.20.1.21585","volume":"20","author":"V Haldane","year":"2017","unstructured":"Haldane V, Cervero-Liceras F, Chuah FL, Ong SE, Murphy G, Sigfrid L, Watt N, Balabanova D, Hogarth S, Maimaris W, et al. Integrating HIV and substance use services: a systematic review. J Int AIDS Soc. 2017;20(1):21585.","journal-title":"J Int AIDS Soc"},{"key":"3918_CR12","doi-asserted-by":"crossref","unstructured":"Karumbi J, Garner P: Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2015, 2015 (5) (no pagination)(CD003343).","DOI":"10.1002\/14651858.CD003343.pub4"},{"issue":"3","key":"3918_CR13","doi-asserted-by":"publisher","first-page":"206","DOI":"10.3109\/00952990.2011.643975","volume":"38","author":"RD Bruce","year":"2012","unstructured":"Bruce RD, Eiserman J, Acosta A, Gote C, Lim JK, Altice FL. Developing a modified directly observed therapy intervention for hepatitis C treatment in a methadone maintenance program: implications for program replication. Am J Drug Alcohol Abuse. 2012;38(3):206\u201312.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"Suppl 1","key":"3918_CR14","first-page":"23","volume":"41","author":"YM Achmad","year":"2009","unstructured":"Achmad YM, Istiqomah AN, Iskandar S, Wisaksana R, van Crevel R, Hidayat T. Integration of methadone maintenance treatment and HIV care for injecting drug users: a cohort study in Bandung, Indonesia. Acta Med Indones. 2009;41(Suppl 1):23\u20137.","journal-title":"Acta Med Indones"},{"issue":"4","key":"3918_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.jsat.2012.07.011","volume":"43","author":"JM Tetrault","year":"2012","unstructured":"Tetrault JM, Moore BA, Barry DT, O'Connor PG, Schottenfeld R, Fiellin DA, Fiellin LE. Brief versus extended counseling along with buprenorphine\/naloxone for HIV-infected opioid dependent patients. J Subst Abuse Treat. 2012;43(4):433\u20139.","journal-title":"J Subst Abuse Treat"},{"key":"3918_CR16","unstructured":"Integrated care models: an overview. In. \n                    http:\/\/www.euro.who.int\/__data\/assets\/pdf_file\/0005\/322475\/Integrated-care-models-overview.pdf:\n                    \n                   World Health Organization; 2016."},{"issue":"8","key":"3918_CR17","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1176\/appi.ajp.2012.11111616","volume":"169","author":"E Woltmann","year":"2012","unstructured":"Woltmann E, Grogan-Kaylor A, Perron B, Georges H, Kilbourne AM, Bauer MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatry. 2012;169(8):790\u2013804.","journal-title":"Am J Psychiatry"},{"issue":"18","key":"3918_CR18","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1097\/QAD.0000000000000879","volume":"29","author":"N Crepaz","year":"2015","unstructured":"Crepaz N, Baack BN, Higa DH, Mullins MM. Effects of integrated interventions on transmission risk and care continuum outcomes in persons living with HIV: Meta-analysis, 1996-2014. Aids. 2015;29(18):2371\u201383.","journal-title":"Aids"},{"issue":"3","key":"3918_CR19","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.drugalcdep.2012.11.013","volume":"129","author":"P Grenfell","year":"2013","unstructured":"Grenfell P, Baptista Leite R, Garfein R, de Lussigny S, Platt L, Rhodes T. Tuberculosis, injecting drug use and integrated HIV-TB care: A review of the literature. Drug Alcohol Depend. 2013;129(3):180\u2013209.","journal-title":"Drug Alcohol Depend"},{"key":"3918_CR20","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.drugpo.2017.07.002","volume":"47","author":"S Bajis","year":"2017","unstructured":"Bajis S, Dore GJ, Hajarizadeh B, Cunningham EB, Maher L, Grebely J. Interventions to enhance testing, linkage to care and treatment uptake for hepatitis C virus infection among people who inject drugs: A systematic review. Int J Drug Policy. 2017;47:34\u201346.","journal-title":"Int J Drug Policy"},{"key":"3918_CR21","doi-asserted-by":"crossref","unstructured":"Hunt GE, Siegfried N, Morley K, Sitharthan T, Cleary M. Psychosocial interventions for people with both severe mental illness and substance misuse. In:  The Cochrane database of systematic reviews. 2013\/10\/05 edn; 2013: Cd001088.","DOI":"10.1002\/14651858.CD001088.pub3"},{"key":"3918_CR22","unstructured":"Wells GA, Shea B, O'Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS). In., vol. 2018. \n                    http:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp\n                    \n                  ."},{"key":"3918_CR23","unstructured":"CONSORT 2010 checklist. In. \n                    http:\/\/www.consort-statement.org\/download\/Media\/Default\/Downloads\/CONSORT%202010%20Checklist.doc:\n                    \n                   CONSORT - Consolidated Standards of Reporting Trials; 2010."},{"issue":"10","key":"3918_CR24","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","volume":"62","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62(10):1006\u201312.","journal-title":"J Clin Epidemiol"},{"issue":"8","key":"3918_CR25","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/cid\/ciw416","volume":"63","author":"AJ Low","year":"2016","unstructured":"Low AJ, Mburu G, Welton NJ, May MT, Davies CF, French C, Turner KM, Looker KJ, Christensen H, McLean S, et al. Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis. Clin Infect Dis. 2016;63(8):1094\u2013104.","journal-title":"Clin Infect Dis"},{"key":"3918_CR26","doi-asserted-by":"crossref","unstructured":"Groessl EJ, Liu L, Sklar M, Ho SB: HCV Integrated Care: A Randomized Trial to Increase Treatment Initiation and SVR with Direct Acting Antivirals. International Journal of Hepatology 2017, 2017 (no pagination)(5834182).","DOI":"10.1155\/2017\/5834182"},{"issue":"11","key":"3918_CR27","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.cgh.2015.02.022","volume":"13","author":"SB Ho","year":"2015","unstructured":"Ho SB, Brau N, Cheung R, Liu L, Sanchez C, Sklar M, Phelps TE, Marcus SG, Wasil MM, Tisi A, et al. Integrated Care Increases Treatment and Improves Outcomes of Patients With Chronic Hepatitis C Virus Infection and Psychiatric Illness or Substance Abuse. Clin Gastroenterol Hepatol. 2015;13(11):2005\u20132014.e2003.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"3918_CR28","doi-asserted-by":"publisher","first-page":"356","DOI":"10.2174\/157016212800792504","volume":"10","author":"GV Sanchez","year":"2012","unstructured":"Sanchez GV, Llibre JM, Torrens M, Sanvisens A, Mateu G, Knobel H, Langohr K, Santos JR, Muga R. Effectiveness of antiretroviral therapy in HIV-1-infected active drug users attended in a drug abuse outpatient treatment facility providing a multidisciplinary care strategy. Curr HIV Res. 2012;10(4):356\u201363.","journal-title":"Curr HIV Res"},{"issue":"4","key":"3918_CR29","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1037\/0278-6133.26.4.488","volume":"26","author":"JM Simoni","year":"2007","unstructured":"Simoni JM, Pantalone DW, Plummer MD, Huang B. A randomized controlled trial of a peer support intervention targeting antiretroviral medication adherence and depressive symptomatology in HIV-positive men and women. Health Psychol. 2007;26(4):488\u201395.","journal-title":"Health Psychol"},{"issue":"11","key":"3918_CR30","doi-asserted-by":"publisher","first-page":"704","DOI":"10.7326\/0003-4819-152-11-201006010-00003","volume":"152","author":"GM Lucas","year":"2010","unstructured":"Lucas GM, Chaudhry A, Hsu J, Woodson T, Lau B, Olsen Y, Keruly JC, Fiellin DA, Finkelstein R, Barditch-Crovo P, et al. Clinic-based treatment of opioid-dependent HIV-infected patients versus referral to an opioid treatment program: A randomized trial. Ann Intern Med. 2010;152(11):704\u201311.","journal-title":"Ann Intern Med"},{"issue":"6","key":"3918_CR31","doi-asserted-by":"publisher","first-page":"e91","DOI":"10.1016\/j.drugpo.2013.09.001","volume":"24","author":"O Morozova","year":"2013","unstructured":"Morozova O, Dvoryak S, Altice FL. Methadone treatment improves tuberculosis treatment among hospitalized opioid dependent patients in Ukraine. Int J Drug Policy. 2013;24(6):e91\u20138.","journal-title":"Int J Drug Policy"},{"issue":"3","key":"3918_CR32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0376-8716(01)00208-3","volume":"66","author":"SL Batki","year":"2002","unstructured":"Batki SL, Gruber VA, Bradley JM, Bradley M, Delucchi K. A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users. Drug Alcohol Depend. 2002;66(3):283\u201393.","journal-title":"Drug Alcohol Depend"},{"key":"3918_CR33","doi-asserted-by":"publisher","first-page":"1194A","DOI":"10.1002\/hep.24521","volume":"54","author":"SB Ho","year":"2011","unstructured":"Ho SB, Groessl EJ, Weingart KR, Ward M, Sklar M, Robinson S, Johnson N, Phelps TE, Marcus S, Cheung R, et al. Prospective multicenter evaluation of hepatitis C patients for psychiatric\/substance use risk factors that reduce likelihood of antiviral treatment. Hepatology. 2011;54:1194A\u20135A.","journal-title":"Hepatology"},{"issue":"3","key":"3918_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/713612419","volume":"10","author":"JL Sorensen","year":"1998","unstructured":"Sorensen JL, Mascovich A, Wall TL, DePhilippis D, Batki SL, Chesney M. Medication adherence strategies for drug abusers with HIV\/AIDS. AIDS Care. 1998;10(3):297\u2013312.","journal-title":"AIDS Care"},{"issue":"Suppl 1","key":"3918_CR35","doi-asserted-by":"publisher","first-page":"S22","DOI":"10.1097\/QAI.0b013e318209751e","volume":"56","author":"FL Altice","year":"2011","unstructured":"Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, et al. HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine\/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr. 2011;56(Suppl 1):S22\u201332.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"7","key":"3918_CR36","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1371\/journal.pmed.0040238","volume":"4","author":"SA Munro","year":"2007","unstructured":"Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4(7):e238.","journal-title":"PLoS Med"},{"issue":"9137","key":"3918_CR37","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/S0140-6736(98)04022-7","volume":"352","author":"M Zwarenstein","year":"1998","unstructured":"Zwarenstein M, Schoeman JH, Vundule C, Lombard CJ, Tatley M. Randomised controlled trial of self-supervised and directly observed treatment of tuberculosis. Lancet (London, England). 1998;352(9137):1340\u20133.","journal-title":"Lancet (London, England)"},{"key":"3918_CR38","unstructured":"An Expanded DOTS Framework for Effective Tuberculosis Control. Stop TB Communicable Disease. In. \n                    https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/67232\/WHO_CDS_TB_2002.297.pdf;jsessionid=EC1F4973A8C7246C716B7580BD0557DE?sequence=1:\n                    \n                   World Health Organization; 2002."},{"issue":"8","key":"3918_CR39","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/S0002-9343(01)00695-7","volume":"110","author":"RE Chaisson","year":"2001","unstructured":"Chaisson RE, Barnes GL, Hackman J, Watkinson L, Kimbrough L, Metha S, Cavalcante S, Moore RD. A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users. Am J Med. 2001;110(8):610\u20135.","journal-title":"Am J Med"},{"key":"3918_CR40","unstructured":"Progress report on access to hepatitis C treatment - focus on overcoming barriers in low- and middle-income countries. In. \n                    http:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/260445\/WHO-CDS-HIV-18.4-eng.pdf;jsessionid=192D3F16578C963DA7651426EE028132?sequence=1:\n                    \n                   World Health Organization; 2018."},{"issue":"5","key":"3918_CR41","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s40273-017-0604-3","volume":"36","author":"T Wisloff","year":"2018","unstructured":"Wisloff T, White R, Dalgard O, Amundsen EJ, Meijerink H, Lovlie AL, Klovstad H. Economic Evaluation of Direct-Acting Antivirals for Hepatitis C in Norway. PharmacoEconomics. 2018;36(5):591\u2013601.","journal-title":"PharmacoEconomics"},{"issue":"11","key":"3918_CR42","doi-asserted-by":"publisher","first-page":"e510","DOI":"10.1016\/S2352-3018(16)30091-1","volume":"3","author":"S Kanters","year":"2016","unstructured":"Kanters S, Vitoria M, Doherty M, Socias ME, Ford N, Forrest JI, Popoff E, Bansback N, Nsanzimana S, Thorlund K, et al. Comparative efficacy and safety of first-line antiretroviral therapy for the treatment of HIV infection: a systematic review and network meta-analysis. The lancet HIV. 2016;3(11):e510\u201320.","journal-title":"The lancet HIV"},{"key":"3918_CR43","unstructured":"Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection. In., 2nd edn: World Health Organization; 2016."},{"key":"3918_CR44","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.drugpo.2017.07.021","volume":"47","author":"BL Norton","year":"2017","unstructured":"Norton BL, Fleming J, Bachhuber MA, Steinman M, DeLuca J, Cunningham CO, Johnson N, Laraque F, Litwin AH. High HCV cure rates for people who use drugs treated with direct acting antiviral therapy at an urban primary care clinic. Int J Drug Policy. 2017;47:196\u2013201.","journal-title":"Int J Drug Policy"},{"key":"3918_CR45","volume-title":"Meta-analysis of empirical studies concerining the effects of medicines and illegal drugs including pharmacokinetics on safe driving. Driving under the influence of drugs, alcohol, and medicines","author":"G Berghaus","year":"2011","unstructured":"Berghaus G, Sticht G, Grellner W, Lenz D, Naumann T, Wiesenm\u00fclle S. Meta-analysis of empirical studies concerining the effects of medicines and illegal drugs including pharmacokinetics on safe driving. Driving under the influence of drugs, alcohol, and medicines; 2011."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-3918-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-3918-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,2]],"date-time":"2020-04-02T23:05:59Z","timestamp":1585868759000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-3918-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3918"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-3918-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,4]]},"assertion":[{"value":"29 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"306"}}